CYSLTR1 and colorectal carcinoma: In our recent study, we showed that BDNF with CYSLTR1 and CD66B together or individually identified the high-risk group or were used as strong prognostic markers in CRC patients, and these markers had a significant role on CC progression in the mice xenograft model [13,21].